For example, m6A enhances the stability of oncogenic genes such as c‐Myc, AKT, and PD‐L1 (Liu et al. 2023, Ni et al. 2022, Zeng et al. 2024), which facilitate tumor progression and immune evasion. Here, AKT1 is linked to neoplasm.